ROIV
Roivant Sciences Ltd
$34.58
▲ +1.90%
+$0.65
NASDAQ · Healthcare · Biotechnology
Roivant Sciences Ltd
ROIV · NASDAQ · Healthcare · Biotechnology
$34.58
▲ +1.90% · +$0.65 today
fundamentals47.4 /100 vs peers · 74% coverage
mixed
4 of 5 metrics · 75% coverage
Revenue growth (TTM)-89.2
733% below Sector 5Y avg avgSector 5Y avg: 14.1
EPS growth (TTM)-84.7
832% below Sector 5Y avg avgSector 5Y avg: 11.6
EPS forecast (5Y)
No EPS forecast (5Y) dataSector fwd avg: 14.4
EPS next year21.8
strong pace
EPS growth (Q/Q)227.8
strong pace
Missing inputs are treated as neutral uncertainty; compared with sector peers where available.
vs sector peers
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| $24.40B | - | -71.6% | 47 |
 | $10.45B | 17.9 | +23.5% | 78 |
 | $4.94B | 20.5 | - | 78 |
 | $27.61B | 30.6 | - | 77 |
 | $1.13T | 43.0 | - | 76 |
US stock research
About Roivant Sciences Ltd (ROIV) stock
Roivant Sciences Ltd trades on NASDAQ under the ticker ROIV. This page brings the latest available price, returns, valuation, growth, analyst context, earnings dates, and relevant headlines into one research view. Use the timestamp to distinguish current market data from slower-moving fundamentals.
Market snapshot updated Jul 17, 2026, 7:00 PM UTC.
- Latest available price
- $34.58
- Day change
- +1.9%
- Market cap
- $20.56B
- P/E (TTM)
- 0.0
- Revenue growth
- -71.6%
- Industry
- Biotechnology
Stocksbrew for agents
Ask your AI about ROIV with current Stocksbrew data.
It can retrieve the current call, target, drivers, risks, and freshness before answering.
Claude Code
Cursor
Codex
Your agent